Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

YanWei Li

6PUBLICATIONS

1CO-AUTHORS

Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Traditional Chinese medicine and treatments

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Jul 10, 2026

YBX1 Promotes Malignant Progression of HNSCC via Stabilizing NSUN2-m5C Modified ATF4 mRNA.

|Mar 15, 2025

Aumolertinib plus chemotherapy as first-line treatment for advanced NSCLC with EGFR exon 19 deletion or exon 21 L858R: a phase II trial.

Yanwei Li, Chenguang Li, Xiaoliang Zhao

|Oct 08, 2024

Efficacy and safety of camrelizumab-based comprehensive treatment for non-small cell lung cancer: a systematic review and meta-analysis.

Nuerbiyamu Maimaitiyiming, Yue Li, Yunfeng Cao

|Sep 05, 2022

Systematic Analysis of Molecular Subtypes and Immune Prediction Based on CD8 T Cell Pattern Genes Based on Head and Neck Cancer.

Li Yanwei, Feng He, Shuang Liu

|Aug 10, 2022

Traditional Chinese medicine formula 01 for nasopharyngeal carcinoma (NPC01) for head & neck cancer and health-related quality of life: a retrospective study.

Li Yanwei, He Feng, Wang Xudong

|Jan 24, 2022

Apatinib and Ginsenoside-Rb1 Synergetically Control the Growth of Hypopharyngeal Carcinoma Cells.

YanWei Li, Feng He, Yu Zhang

Pageof 1

Frequent Collaborators

1 joint publications

Feng He

Frequent Collaborators

1 joint publications

Feng He